Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice

Медицинский совет

G. N. Schukina¹  O. D. Ostroumova¹  V. M. Fomina¹ 

[1] MSUMD named after A.I. Evdokimov, First MSMU named after I.M.Sechenov;

关键词: hypertension;    atherosclerosis;    coronary heart disease;    stroke;    ace inhibitors;    ramipril;   

DOI  :  10.21518/2079-701X-2013-9-44-49

来源: DOAJ

【 摘 要 】

The article focuses on differential choice of ACE inhibitor in clinical practice. Mechanisms of action common for all drugs in this group, indications and benefits are described. Differences in pharmacokinetic features, RAAS blockade, additional unique attributes, indications and strength of evidence for the class representative ramipril are highlighted. There is clinical data of Russian studies on anti-hypertensive effectiveness and anti-atherosclerotic properties of Hartil® (ramipril,"EGIS", Hungary).

【 授权许可】

Unknown